(Q53991841)

23 May 2018

title

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001. (English)

1 reference

23 May 2018

main subject

anti-retroviral agent

0 references

1 reference

Panel on Clinical Practices for Treatment of HIV Infection

series ordinal

1 reference

23 May 2018

publication date

1 May 2001

1 reference

23 May 2018

published in

HIV Clinical Trials

1 reference

23 May 2018

volume

1 reference

23 May 2018

issue

1 reference

23 May 2018

page(s)

227-306

1 reference

23 May 2018

Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats

cites work

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Zidovudine-associated embryonic toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Liver disease in pregnancy and fetal fatty acid oxidation defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Comparative distribution and embryotoxicity of hydroxyurea in pregnant rats and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Drug-induced limb dysplasias in fetal rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

Perinatal Exposure to Zidovudine — Benefits and Risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FRWG0-49RM-GQH4-5BB3

10.1310/RWG0-49RM-GQH4-5BB3

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018